id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2026-N-0826-0001,FDA,FDA-2026-N-0826,"Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public
Docket; Request for Comments— United States (U.S.) 2026–2027 Influenza Vaccine Strain Composition",Notice,Request for Comments,2026-02-12T05:00:00Z,2026,2,2026-02-12T05:00:00Z,2026-03-12T03:59:59Z,2026-02-28T10:00:15Z,2026-02787,1,0,09000064b91a649f